Brief: Peak Bio, Inc. Announces Amendment And Continued Access To Equity Line Of Up To $100 Million USD Via An Accelerated Common Stock Purchase Transaction With White Lion Capital
24/08/2023 21:48
Peak Bio Inc PKBO.PK :
* PEAK BIO, INC. ANNOUNCES AMENDMENT AND CONTINUED ACCESS TO
EQUITY LINE OF UP TO $100 MILLION USD VIA AN ACCELERATED COMMON
STOCK PURCHASE TRANSACTION WITH WHITE LION CAPITAL
Source text for Eikon: ID:nGNE3LvSt8
Further company coverage: PKBO.PK
Recent news on Peak Bio
See all newsBrief: Akari Therapeutics Announces Shareholder Approval In Connection With Peak Bio Merger
Brief: Akari Therapeutics And Peak Bio Announce Portfolio Prioritization Plan For Combined Go-Forward Merger Entity
Brief: Peak Bio, Inc. Announces Up-Listing To Otcqb Market
Brief: Peak Bio Announces Its Application To Uplist To The Otcqb Venture Market
Brief: Peak Bio, Inc. Announces Amendment And Continued Access To Equity Line Of Up To $100 Million USD Via An Accelerated Common Stock Purchase Transaction With White Lion Capital